The active ingredient in Zepbound (for weight management) and Mounjaro (for type 2 diabetes). It's a once-weekly injectable that acts on two gut-hormone receptors (GLP-1 and GIP) which is why head-to-head trial data shows somewhat greater average weight loss than semaglutide. As with semaglutide, "compounded tirzepatide" refers to non-FDA-approved copies.
Related terms: Zepbound · Mounjaro · Semaglutide · GIP receptor · Compounded medication
See also: Wegovy vs. Zepbound